These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 12468575)

  • 21. Screening for primary aldosteronism--normal ranges for aldosterone and renin in three South African population groups.
    Rayner BL; Myers JE; Opie LH; Trinder YA; Davidson JS
    S Afr Med J; 2001 Jul; 91(7):594-9. PubMed ID: 11544978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
    Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients.
    Flack JM; Oparil S; Pratt JH; Roniker B; Garthwaite S; Kleiman JH; Yang Y; Krause SL; Workman D; Saunders E
    J Am Coll Cardiol; 2003 Apr; 41(7):1148-55. PubMed ID: 12679215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension.
    Gonzaga CC; Gaddam KK; Ahmed MI; Pimenta E; Thomas SJ; Harding SM; Oparil S; Cofield SS; Calhoun DA
    J Clin Sleep Med; 2010 Aug; 6(4):363-8. PubMed ID: 20726285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of low-dose spironolactone in subjects with resistant hypertension.
    Nishizaka MK; Zaman MA; Calhoun DA
    Am J Hypertens; 2003 Nov; 16(11 Pt 1):925-30. PubMed ID: 14573330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension.
    Dudenbostel T; Ghazi L; Liu M; Li P; Oparil S; Calhoun DA
    Hypertension; 2016 Oct; 68(4):995-1003. PubMed ID: 27528066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity.
    Nguyen G; Blanchard A; Curis E; Bergerot D; Chambon Y; Hirose T; Caumont-Prim A; Tabard SB; Baron S; Frank M; Totsune K; Azizi M
    Hypertension; 2014 Feb; 63(2):297-302. PubMed ID: 24218434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status.
    Ghazi L; Dudenbostel T; Lin CP; Oparil S; Calhoun DA
    J Hypertens; 2016 May; 34(5):1005-10. PubMed ID: 26886564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuum of Renin-Independent Aldosteronism in Normotension.
    Baudrand R; Guarda FJ; Fardella C; Hundemer G; Brown J; Williams G; Vaidya A
    Hypertension; 2017 May; 69(5):950-956. PubMed ID: 28289182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study.
    Lim PO; Jung RT; MacDonald TM
    Br J Clin Pharmacol; 1999 Nov; 48(5):756-60. PubMed ID: 10594479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride.
    Graudal NA; Hubeck-Graudal T; Jurgens G
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004022. PubMed ID: 28391629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The salivary sodium/potassium ratio in hypertension: relation to race and plasma renin activity.
    Adlin EV; Marks AD; Channick BJ
    Clin Exp Hypertens A; 1982; 4(9-10):1869-80. PubMed ID: 6754154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
    Schwartz GL; Turner ST
    Clin Chem; 2005 Feb; 51(2):386-94. PubMed ID: 15681560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.
    Oelkers W; Diederich S; Bähr V
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3266-70. PubMed ID: 10999820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of dietary potassium in the hyperaldosteronism and hypertension of the remnant kidney model.
    Ibrahim HN; Hostetter TH
    J Am Soc Nephrol; 2000 Apr; 11(4):625-631. PubMed ID: 10752521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension, angiotensin II, aldosterone, and race.
    Ben-Yehuda O
    J Am Coll Cardiol; 2003 Apr; 41(7):1156-8. PubMed ID: 12679216
    [No Abstract]   [Full Text] [Related]  

  • 40. Primary aldosteronism: diagnostic and therapeutic considerations.
    Nishizaka MK; Calhoun DA
    Curr Cardiol Rep; 2005 Nov; 7(6):412-7. PubMed ID: 16256009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.